MISSISSAUGA, ON, Aug. 2, 2023 /CNW/ - Jazz Pharmaceuticals Canada Inc. today announced that the Company has entered into a Letter of Intent with the pan-Canadian Pharmaceutical Alliance regarding.
Ozempic, a drug approved to treat Type 2 diabetes, is in short supply in the U.S. after social media and prominent figures popularized the medication as a solution for weight loss.
By Ashley Baddeley and Tamara Rader More than 700,000 Canadians are currently living with dementia, a syndrome that leads to progressive memory loss and a deterioration in cognition over time. Associated symptoms range from mild and not debilitating (i.e., forgetfulness, limited attention span, mood swings, and mild coordination issues) to all-encompassing (i.e., inability to communicate […]